Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-06-06
1997-07-22
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514567, A61K 31165, A61K 31195
Patent
active
056504438
ABSTRACT:
2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.
REFERENCES:
Remington's Pharmaceutical Sciences, 15th ed. Mack Pub. Co., 1975, pp. 855, 857-858.
Klockgether et al. "NMDA Antagonists potentiate . . . " Annals of Neurology, vol. 28 No. 4, 1990. pp. 539-546.
R. Griffith et al. "Preclinical Neuroprotective . . . " Abstracts of Papers of the American Chemical Society, vol. 201, No. 1-2, 1991., p. 22.
R.V. Eller et al. "Remacemide and L Dopa . . . " Soc. Neurosci. Abstract, vol. 18 No. 1-2, 1992, p. 1080.
Harris Eric W.
Johnson Peter
Watkins Barry E.
Astra Aktiebolag
Spivack Phyllis G.
LandOfFree
Method of treatment of parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of parkinson's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560368